Cognite and ABB Collaborate to Integrate Agentic AI into Industrial Applications to Deliver Faster Workflows
21.5.2026 12:00:00 CEST | Business Wire | Press Release
Cognite, the leader in Industrial AI, today announced a collaboration with ABB to assess how advanced industrial AI and data capabilities can be integrated to solve key use cases in the energy sector. By adding an agentic layer to established industrial applications, including ABB Ability™ SafetyInsight™ and ABB Ability™ AlarmInsight™, using the Cognite Industrial AI and Data platform, the collaboration aims to enable "agent-to-agent" orchestration. Leading energy producer Aker BP has signed on as the first customer to implement this new generation of intelligent offerings as part of its strategy to further increase its current production efficiency of 96% and achieve a production growth target of 525,000 barrels of oil equivalent per day by 2028.
Transforming Data into Actionable Business Value
By breaking down traditional data silos and shifting to outcome-based software orchestration, the collaboration aims to deliver significant business value to ABB and Cognite customers, including Aker BP:
- Faster Workflows: Agentic orchestration will allow complex processes, such as multi-system risk assessments and alarm rationalization, to be completed an order of magnitude faster than manual coordination
- Accelerated Analysis and Decision Making: Established applications like ABB Ability SafetyInsight and ABB Ability AlarmInsight can now operate as active agents that autonomously interpret data, reason through logic, and trigger cross-system actions
- Improved Risk Mitigation: The agentic layer will connect disparate data points in real time, reducing human error and preventing information overload for operators in critical-path environments
“Our goal at Aker BP is to be a leader in efficient operations, and that requires us to maximize the value of every piece of software in our stack," said Paula Doyle, Chief Digital Officer at Aker BP. "This agentic framework allows us to scale our digital strategy, moving us closer to our goal of deploying hundreds of agents by 2026, all working in concert to solve complex workflows that were once highly manual.”
“ABB is committed to helping our customers transition toward autonomous operations,” added Gino Hernandez, Head of Global Digital Business at ABB’s Energy Industries Division. “By integrating critical industrial applications such as alarm and safety insights with an agent-to-agent orchestration model, customers can prioritize critical interventions, accelerate decision making, and reduce risk to enable safer and more reliable operations.”
Dr. John Markus Lervik, Founder at Cognite, concluded: “Aker BP is redefining what it means to be an industrial company. By fusing ABB’s domain expertise and industrial applications with Cognite’s Industrial AI innovation, we are moving the energy industry toward a new pattern of operating where systems 'talk' to one another to solve its most complex challenges.”
About Cognite
Cognite makes AI work for industry. Leading energy, manufacturing, and power & renewables enterprises choose Cognite to deliver secure, trustworthy, and real-time data to transform their asset-heavy operations to be safer, more sustainable, and profitable. Cognite provides a user-friendly, secure, and scalable industrial data & AI platform that makes it easy for all decision-makers, from the field to remote operations centers, to access and understand complex industrial data, collaborate in real-time, and build a better tomorrow. Visit us at www.cognite.com, and follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260521650379/en/
Contacts
Media Contact:
media@cognite.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press Release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press Release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press Release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press Release
Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr
Unpack ’26 avslöjar sommarens resetrender: Efterfrågan på inrikes ökar21.5.2026 12:34:00 CEST | Pressmeddelande
Idag släpper Hotels.com Unpack ’26 – Sommar: The Trends in Travel, den senaste upplagan av sin branschledande rapport som avslöjar vilka beteenden som påverkar sommarens resebeslut. En efterfrågan på inrikesresor dominerar sommarens semesterplanering. Sociala samtal som omnämner inrikesresor har ökat med 77% globalt jämfört med föregående år, och nästan fördubblats i Sverige, där hela 57% av svenska resenärer uppger att de planerar en inrikesresa i sommar*. Sommarupplagan av Unpack bygger på insikter från huvudrappporten Unpack ’26: The Trends in Travel™ och behandlar såväl stora sportevenemang som streaminginspirerade resor för att se vart resenärer är på väg i sommar. Varje trend bygger på förstapartsdata från Hotels.com® och insikter från resenärer och social listening. “I sommar saktar resandet inte ner, men det omformas. Eftersom stora globala händelser och stigande kostnader påverkar beslut, stannar resenärer antingen närmare hemmet eller söker sig till destinationer där de kan f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom